JPRN-jRCT1031210200招募中4 期
Real-life effectiveness of vortioxetine on goal achievement and work productivity for patients with major depressive disorder in Japan - VGOAL-J
Hongo Seiji0 个研究点目标入组 120 人开始时间: 2021年7月15日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 20age old 至 <= 65age old（—）
- 性别
- All
入选标准
- •The patient is an outpatient, treated in a general practitioner or psychiatric outpatient practice
- •- The patient has a diagnosis of major depressive episode according to the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSMV) (F32.x and F33.x)
- •- The patient is initiating treatment with vortioxetine according to the local Japanese label
排除标准
- •- The patient is concurrently participating in a clinical trial
- •- The patient has a diagnosis of schizophrenia or other psychotic disorder according to DSM-V
- •- The patient has a diagnosis of bipolar disorder according to DSM-V
- •- The patient has a substance use disorders other than tobacco use disorder
- •- The patient has dementia or other neurodegenerative diseases significantly impacting cognitive functioning
- •- The patient has a mood disorder due to a general medical condition or substances
研究者
相似试验
尚未招募
2 期
A randomized placebo-controlled trial of vortioxetine for obsessive-compulsive disorderCTRI/2023/12/060748Indican Council of Medical Research
招募中
不适用
Relationship between the effects of vortioxetine and sleep EEG findings in depressioDepressionJPRN-UMIN000047036ihon University Itabashi Hospital30
已完成
4 期
Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive DisorderMajor Depressive DisorderNCT02972632Takeda123
已完成
3 期
Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderDepressive Disorder, MajorNCT01163266Takeda462
已完成
3 期
A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous MedicationMajor Depressive DisorderNCT01488071H. Lundbeck A/S495